Rentschler and Leukocare announce strategic alliance and equity investment

06-Feb-2017 - Rentschler Biotechnologie GmbH, Laupheim and Leukocare AG, Martinsried announced a strategic alliance under which Leukocare will become the specialized technology partner and the exclusive formulation developer for Rentschler’s biopharmaceuticals business. Rentschler in return will become the ...

LEUKOCARE provides key technologies for tumour diagnosis in personalized medicine research project

Multi-national consortium receives €6 million EU grant

06-Jul-2012 - LEUKOCARE AG announced that it will receive funding from the EU FP7 grant programme to participate in a four-year international research project aimed at developing a new blood apheresis device for in vivo trapping of circulating tumour cells.The consortium of eleven companies, universities, and ...

LEUKOCARE to receive Frost & Sullivan’s 2011 Biotechnology Investment Opportunity Award

16-Feb-2012 - LEUKOCARE has been awarded 2011’s “Biotechnology Investment Opportunity Award”, by the independent research consultancy Frost & Sullivan.In the citation for the 2011 European Biotechnology Industry Early Stage Investment Opportunity Award, Frost & Sullivan focuses on the innovative nature of ...

Leukocare and Sanofi Pasteur sign cooperation agreement for vaccine stabilization

27-Jul-2011 - Leukocare AG announced the signing of a cooperation agreement with Sanofi Pasteur, the vaccines division of Sanofi. As part of this cooperation, Sanofi Pasteur will explore Leukocare ’s SPS platform technology to enhance the shelf-life of selected vaccine formulations.Leukocare’s Stabilizing and ...

LEUKOCARE signs cooperation agreement with Sterigenics

19-Nov-2010 - LEUKOCARE AG announced the signing of a cooperation agreement with Sterigenics. As part of this cooperation, LEUKOCARE plans to use their Stabilizing and Protecting Solutions (SPS) technology together with Sterigenics’ irradiation expertise in order to establish new sterilization procedures for ...

Leukocare appoints VP Business Development

Expands team and relocates operations to the IZB in Martinsried/Munich

16-Jun-2010 - Leukocare AG announced that it has appointed Dr. Wolfram Altenhofen as its new VP Business Development. Dr. Altenhofen previously was responsible for building up sales forces in Europe and India. A pharmacist by profession, he received his Ph.D. in biophysics from Forschunszentrum Jülich. ...

LEUKOCARE has been granted both ISO 9001 and ISO 13485 certification

26-Feb-2010 - LEUKOCARE AG, a privately-owned company developing innovative biofunctional surfaces using its proprietary stabilizing postcoating technology, announced that it has successfully established a Quality Management System (QMS) in accordance with ISO 9001:2008 and ISO 13485:2003 standards for medical ...